The onset of highly effective CFTR modulator therapy has improved pulmonary function and mucociliary clearance in many CF patients, however, beneficial outcomes on fungal infections remain to be seen (Bercusson et al., 2021; Chesnay et al., 2022). Here, CFTR is linked to fungal infectious disease.